Many United Healthcare (UHC) plans will cover Ozempic, but only for Type 2 diabetes, and some of them may have quantity limits and prior authorization requirements
Analyzing medical and outpatient pharmacy claims, the researchers found that semaglutide use was associated with a 49% lower adjusted hazard of COVID-19-associated mortality, especially relevant since obesity or overweight and type 2 diabetes, the primary conditions for which semaglutide may be prescribed, have consistently been associated with an increased mortality risk
Wegovy isnt the end of the road for Novo Nordisk, Brett says
Prevention is better than cure
Tauqeer Z, Bracha P, Hua P, Yu Y, Cui QN, VanderBeek BL